Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-15-004814
Filing Date
2015-08-20
Accepted
2015-08-20 13:08:11
Documents
1
Period of Report
2015-08-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT gff4_holler082015.html 4  
1 OWNERSHIP DOCUMENT gff4_holler082015.xml 4 8171
  Complete submission text file 0001171843-15-004814.txt   9520
Mailing Address SUITE 707 1177 WEST HASTINGS ST VANCOVER BRITISH COL A1
Business Address
HOLLER FRANK A (Reporting) CIK: 0000938801 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 151065908

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations